FDA Adverse Event Malfunction Summary report: N

INFUSOR

MDR report key: 3223393 · Received July 12, 2013

Report

Report Number
1416980-2013-18178
Event Type
Malfunction
Date Received
July 12, 2013
Report Date
June 19, 2013
Manufacturer
BAXTER HEALTHCARE - IRVINE
Product Code
MEB
PMA / PMN Number
K071222
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHARMACIST

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION SUMMARY: BAXTER RECEIVED ONE SAMPLE FOR EVALUATION. VISUAL INSPECTION OF THE SAMPLE NOTED A RUPTURED BLADDER IN A NON-FOOTING POSITION. THE RESERVOIR WAS MICROSCOPICALLY EXAMINED. MARKINGS ON THE INTERIOR SURFACE OF THE BLADDER WERE OBSERVED NEAR THE RUPTURE LINE, WHICH IS INDICATION OF EXTERNAL DAMAGE. THE CAUSE OF THE RUPTURE COULD NOT BE DETERMINED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). A BATCH REVIEW WAS CONDUCTED AND REVEALED THAT ALL OF THE ACCEPTANCE CRITERIA WERE MET TO RELEASE THE LOT. THERE WERE NO NON-CONFORMANCES, FAILURES, REWORK, OR DEVIATIONS RELATED TO THE LOT. THERE WERE NO CHANGES TO SPECIFICATIONS, TEST METHODS, PROCESS, EQUIPMENT, OR RAW MATERIALS THAT COULD BE ASSOCIATED WITH THE REPORTED CONDITION. INITIAL EVALUATION CONFIRMED THE REPORTED CONDITION. UPON COMPLETION OF BAXTER'S INVESTIGATION, IF ADDITIONAL RELEVANT INFORMATION IS OBTAINED, A FOLLOW-UP WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT AN INFUSOR HAD A RESERVOIR RUPTURE DURING INFUSION. THE DEVICE WAS FILLED WITH A SOLUTION OF FLUOROURACIL. THERE WAS PATIENT INVOLVEMENT, BUT THERE WAS NO REPORT OF PATIENT INJURY, MEDICAL INTERVENTION NECESSARY, OR ADVERSE REACTION IN ASSOCIATION WITH THIS EVENT. ADDITIONAL INFORMATION WAS REQUESTED BUT IS NOT AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
322689 INFUSOR PUMP, INFUSION, ELASTOMERIC MEB BAXTER HEALTHCARE - IRVINE 12M057

Patients

Seq Age Sex Outcome Treatment
1 FLUOROURACIL